Why Drug Safety Should Not Take a Back Seat to Efficacy

The PLoS Medicine Editors

PLOS Medicine, 2011, vol. 8, issue 9, 1-2

Abstract: The PLoS Medicine editors argue that methodological challenges in monitoring the safety of prescription medications should not mean that drug safety be considered less important than efficacy.

Date: 2011
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1001097 (text/html)
https://journals.plos.org/plosmedicine/article/fil ... 01097&type=printable (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:plo:pmed00:1001097

DOI: 10.1371/journal.pmed.1001097

Access Statistics for this article

More articles in PLOS Medicine from Public Library of Science
Bibliographic data for series maintained by plosmedicine ().